Saxena R, Bushey RT, Campa MJ, Gottlin EB, Guo J, Patz EF Jr, He YW. Promotion of an Antitumor Immune Program by a Tumor-specific, Complement-activating Antibody. J Immunol. 2024 Apr 1.

Saxena R, Gottlin EB, Campa MJ, Bushey RT, Guo J, Patz EF Jr, He YW. Complement factor H: a novel innate immune checkpoint in cancer immunotherapy. Front Cell Dev Biol. 2024 Feb 8.

Patz EF Jr, Gottlin EB, Simon GR. Perspective: rethinking therapeutic strategies in oncology. Front Oncol. 2024 Jan 10;13:1335987.

Bushey RT, Saxena R, Campa MJ, Gottlin EB, He YW, Patz EF Jr. Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103. Mol Cancer Ther. 2023 Jun 1;22(6):778-789.

Gottlin EB, Campa MJ, Gandhi R, Bushey RT, Herndon Nd JE, Patz EF Jr. Prognostic significance of a complement factor H autoantibody in early stage NSCLC. Cancer Biomark. 2022;34(3):385-392.

Bushey RT, Gottlin EB, Campa MJ, Patz EF Jr. Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosis. PLoS One. 2021 Jun 16;16(6):e0252577.

Li X, Zou Y, Li T, Wong TKF, Bushey RT, Campa MJ, Gottlin EB, Liu H, Wei Q, Rodrigo A, Patz EF Jr. Genetic Variants of CLPP and M1AP Are Associated With Risk of Non-Small Cell Lung Cancer.Front Oncol. 2021 Sep 15;11:709829.

Tailor TD, Rao X, Campa MJ, Wang J, Gregory SG, Patz EF Jr. Whole Exome Sequencing of Cell-Free DNA for Early Lung Cancer: A Pilot Study to Differentiate Benign From Malignant CT-Detected Pulmonary Lesions. Front Oncol. 2019 Apr 24;9:317.

Bushey RT, Moody MA, Nicely NL, Haynes BF, Munir Alam SM, Keir ST, Bentley RC, Choudhury KR, Gottlin EB, Campa MJ, Liao H-X and Edward F. Patz, Jr. A Therapeutic Antibody for Cancer, Derived from Single Human B Cells. Cell Reports 2016: 15(7):1505-13.

Campa MJ, Moody MA, Zhang R, Liao HX, Gottlin EB, Patz EF Jr. Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery. Cancer Immunol Immunother. 2016: 65(2) 3226-31.

Campa MJ, Gottlin EB, Bushey RT, Patz EF Jr. Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic Strategy. Cancer Immunol Res 2015: 3(12):1325-32.

Patz EF Jr, Campa MJ, Gottlin EB, Trotter PR, Herndon JE 2nd, Kafader D, Grant RP, Eisenberg M. Biomarkers to help guide management of patients with pulmonary nodules. Am J Respir Crit Care Med. 2013: 188(4):461-5.

Additional publications from the Patz lab can be found by clicking this link.